119 related articles for article (PubMed ID: 22841859)
1. Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations.
Adler M; Deshpande SS; Apland JP; Murray B; Borrell A
Neurochem Int; 2012 Nov; 61(6):866-73. PubMed ID: 22841859
[TBL] [Abstract][Full Text] [Related]
2. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.
Bradford AB; Machamer JB; Russo TM; McNutt PM
Toxicol Appl Pharmacol; 2018 Feb; 341():77-86. PubMed ID: 29366638
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin.
Adler M; Macdonald DA; Sellin LC; Parker GW
Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757
[TBL] [Abstract][Full Text] [Related]
4. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations.
Adler M; Scovill J; Parker G; Lebeda FJ; Piotrowski J; Deshpande SS
Toxicon; 1995 Apr; 33(4):527-37. PubMed ID: 7570638
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps.
Adler M; Capacio B; Deshpande SS
Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273
[TBL] [Abstract][Full Text] [Related]
7. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
[TBL] [Abstract][Full Text] [Related]
8. In vitro and ex vivo screening of candidate therapeutics to restore neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A1.
Beske PH; Bradford AB; Hoffman KM; Mason SJ; McNutt PM
Toxicon; 2018 Jun; 147():47-53. PubMed ID: 29054436
[TBL] [Abstract][Full Text] [Related]
9. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
Bigalke H; Rummel A
Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
[TBL] [Abstract][Full Text] [Related]
11. Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.
Beske PH; Hoffman KM; Machamer JB; Eisen MR; McNutt PM
Sci Rep; 2017 Nov; 7(1):15862. PubMed ID: 29158500
[TBL] [Abstract][Full Text] [Related]
12. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule.
Mayorov AV; Willis B; Di Mola A; Adler D; Borgia J; Jackson O; Wang J; Luo Y; Tang L; Knapp RJ; Natarajan C; Goodnough MC; Zilberberg N; Simpson LL; Janda KD
ACS Chem Biol; 2010 Dec; 5(12):1183-91. PubMed ID: 20936877
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic treatment of botulism with a clinically approved small molecule.
Vazquez-Cintron E; Machamer J; Ondeck C; Pagarigan K; Winner B; Bodner P; Kelly K; Pennington MR; McNutt P
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31996484
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
Thyagarajan B; Potian JG; Garcia CC; Hognason K; Capková K; Moe ST; Jacobson AR; Janda KD; McArdle JJ
Neuropharmacology; 2010 Jun; 58(8):1189-98. PubMed ID: 20211192
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
17. Interactions between heavy metal chelators and botulinum neurotoxins at the mouse neuromuscular junction.
Sheridan RE; Deshpande SS
Toxicon; 1995 Apr; 33(4):539-49. PubMed ID: 7570639
[TBL] [Abstract][Full Text] [Related]
18. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
Zhang P; Ray R; Singh BR; Ray P
Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
[TBL] [Abstract][Full Text] [Related]
19. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.
Machamer JB; Vazquez-Cintron EJ; O'Brien SW; Kelly KE; Altvater AC; Pagarigan KT; Dubee PB; Ondeck CA; McNutt PM
Mol Med; 2022 Jun; 28(1):61. PubMed ID: 35659174
[TBL] [Abstract][Full Text] [Related]
20. BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild-type in murine running wheel assay.
Kutschenko A; Reinert MC; Krez N; Liebetanz D; Rummel A
Neurotoxicology; 2017 Mar; 59():1-8. PubMed ID: 28043867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
